AstraZeneca to sequence 2m genomes in hunt for new drugs
by Reuters from on (#1BC9H)
The UK pharma company is teaming up with pioneer Craig Venter in a huge project to discover new treatments
AstraZeneca has teamed up with genome pioneer Craig Venter to launch a huge gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines.
Related: Treatments for cancers and Alzheimer's on the verge of a breakthrough
Continue reading...